The Pulse – Newsletter for Leaders in the Medical Device Industry – April 2007
10 April 2007
The rapidly changing legislative, reimbursement, regulatory, and technology landscapes, coupled with increasing civil and criminal liability, have posed significant challenges and offered tremendous opportunities for medical device manufacturers.
To help you address these developments, the Medical Device attorneys of Foley & Lardner LLP provide fully integrated experience in U.S. Food and Drug Administration (FDA) and health care regulatory issues, reimbursement, intellectual property law (IP), business law, litigation, and public affairs, enabling us to collaboratively craft effective strategies and implement them with clients.
Read The Pulse newsletter by clicking on the link below.
Author(s)
Related Insights
06 November 2024
November 2024 Midwest Cyber Security Alliance Meeting | Resilience Awakens: Tapping Into Your Inner Force for Managing Stress Effectively
Join us on Wednesday, November 20, 2024, for a very special Midwest Cyber Security Alliance meeting offering a unique, interactive approach to mental wellness, helping professionals thrive in high-stress environments like cybersecurity.
12 November 2024
Events
MEMA Original Equipment Suppliers Annual Conference 2024
Join Foley at the MEMA Original Equipment Suppliers Annual Conference on November 12-13.
05 November 2024
Health Care Law Today
Cancer Drugs: Clinical Trial Issues for Antibody Drug Conjugates (ADCs)/Antibody Therapeutics
Antibody Drug Conjugates (ADCs) are a class of small molecule drugs and an antibody conjugated together by a chemical linker.